The Form 4 filing, a report of changes in an insider's stock ownership, was filed on October 13, 2026. It covers sales dated October 8–9, 2026. McMahon John Patrick was listed as chief operating officer of the travel division at NextTrip (NTRP).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-08 |
| Date of Latest Transaction | 2026-10-09 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 80,000 |
| Price | $2.01 |
| Total Transaction Value | $161,060.00 |
| Insider | |
| Ticker Symbol | NTRP |
| Company | NextTrip, Inc. |
| Insider Name | McMahon John Patrick |
| Insider Title | COO - Travel Division |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 88,414 |
| Position Size Change | 47.50% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of company shares, reported under transaction code S, which identifies a sale. The filing lists four transactions by one insider, McMahon John Patrick.
What was the average price of the transaction?
The average sale price was $2.01325 per share, or $2.01 rounded to the nearest cent. This average covers the four transactions. Separate prices for each sale were not available for this report.
How did this transaction affect the insider's holdings?
He sold 80,000 shares and reported owning 88,414 shares afterward. Based on those figures, he held 168,414 shares before the sales. The shares sold accounted for 47.50% of that earlier balance.
What's the total transaction value?
The total reported value was $161,060.00 for all four sales. This is the total dollar amount, while $2.01325 is the average price per share.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for these sales. Filing footnotes were not available for this report, so further details about any special terms or other circumstances remain unknown.
For research purposes only; not investment advice.